Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 005914

Expand all

PBZ (TRIPELENNAMINE CITRATE)
EQ 25MG HYDROCHLORIDE/5ML
Marketing Status: Discontinued

Active Ingredient: TRIPELENNAMINE CITRATE
Proprietary Name: PBZ
Dosage Form; Route of Administration: ELIXIR; ORAL
Strength: EQ 25MG HYDROCHLORIDE/5ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N005914
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information

PBZ (TRIPELENNAMINE HYDROCHLORIDE)
50MG
Marketing Status: Discontinued

Active Ingredient: TRIPELENNAMINE HYDROCHLORIDE
Proprietary Name: PBZ
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 50MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N005914
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information